跳至主要内容
临床试验/NCT02019849
NCT02019849已完成不适用

Post Market Clinical Follow-Up of Plasmafit® Cup

Aesculap AG2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年6月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Aesculap AG
入组人数
100
试验地点
2
主要终点
Implant Survival Rates

研究概览

简要总结

Twelve months follow-up of implant survival and clinical and radiological follow-up of Plasmafit® Cup.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Minimum age 18 years
  • Indication for cementless total hip arthroplasty
  • Patient consent for study participation
  • Physical and mental willingness to participate at clinical and radiological follow-up

排除标准

  • Patient not available for follow-up
  • Increased anesthetics risks according to the "American Society of Anesthesiology": ASA IV
  • Alcohol or drug abuse
  • Permanent cortisone therapy
  • Clinically relevant infection
  • Pregnancy or planned pregnancy
  • Prior interventions like osteotomy, fracture treatment or prior THA at the concerned hip
  • Acute fracture at the concerned hip
  • Patients needing a cemented hip arthroplasty

结局指标

主要结局

Implant Survival Rates

时间窗: 10 years

Implant survival is analysed at follow-up examinations at 3 months, 12 months, 5 years and 10 years

次要结局

  • Implant Position(3 months, 12 months, 5 years, 10 years)
  • Migration of Plasmafit®(3 months, 12 months, 5 years, 10 years)
  • Clinical Outcome(3 months, 12 months, 5 years, 10 years)
  • Osteolysis(3 months, 12 months, 5 years, 10 years)
  • Ossifications(3 months, 12 months, 5 years, 10 years)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验